Impact of Angiotensin-II receptor blockers on vasogenic edema in glioblastoma patients. (Q49015944)

17 February 2018

title

Impact of Angiotensin-II receptor blockers on vasogenic edema in glioblastoma patients. (English)

1 reference

17 February 2018

1 reference

Antoine Kourilsky

1

1 reference

17 February 2018

Guillaume Bertrand

2

1 reference

17 February 2018

Renata Ursu

3

1 reference

17 February 2018

Jennifer Doridam

4

1 reference

17 February 2018

Ciprian Barlog

5

1 reference

17 February 2018

Thierry Faillot

6

1 reference

17 February 2018

Emmanuel Mandonnet

7

1 reference

17 February 2018

Catherine Belin

8

1 reference

17 February 2018

Christine Levy

9

1 reference

17 February 2018

Antoine F Carpentier

10

1 reference

17 February 2018

publication date

11 January 2016

1 reference

17 February 2018

published in

Journal of Neurology

1 reference

17 February 2018

volume

263

1 reference

17 February 2018

issue

3

1 reference

17 February 2018

page(s)

524-530

1 reference

17 February 2018

https://scigraph.springernature.com/pub.10.1007/s00415-015-8016-9

exact match

0 references

cites work

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-8016-9

Steroid requirements during radiotherapy for malignant gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-8016-9

Dexamethasone treatment in patients with brain metastases and primary brain tumors: do the benefits outweigh the side-effects?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-8016-9

Angiotensin receptors: a new role in cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-8016-9

Multiple angiotensin receptor subtypes in normal and tumor astrocytes in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-8016-9

Blockade of angiotensin AT1a receptor signaling reduces tumor growth, angiogenesis, and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-8016-9

Role of host angiotensin II type 1 receptor in tumor angiogenesis and growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-8016-9

AT1 receptor is present in glioma cells; its blockage reduces the growth of rat glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-8016-9

Captopril inhibits angiogenesis and slows the growth of experimental tumors in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-8016-9

Blockage of angiotensin II type I receptor decreases the synthesis of growth factors and induces apoptosis in C6 cultured cells and C6 rat glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-8016-9

Angiotensin II AT1 receptor blockade decreases brain artery inflammation in a stress-prone rat strain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-8016-9

Angiotensin II induced cerebral microvascular inflammation and increased blood-brain barrier permeability via oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-8016-9

Usefulness of diffusion-weighted MRI with echo-planar technique in the evaluation of cellularity in gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-8016-9

Diffusion-weighted MR imaging of experimental brain tumors in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-8016-9

MR imaging of high-grade cerebral gliomas: value of diffusion-weighted echoplanar pulse sequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-8016-9

Validation of functional diffusion maps (fDMs) as a biomarker for human glioma cellularity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-8016-9

Bradykinin potentiation by ACE inhibitors: a matter of metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-8016-9

Steroid-sparing effects of angiotensin-II inhibitors in glioblastoma patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-8016-9

Angiotensin II AT(1) receptor blockers as treatments for inflammatory brain disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-8016-9

Angiotensin II modulates BBB permeability via activation of the AT(1) receptor in brain endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-8016-9

Angiotensin II controls occludin function and is required for blood brain barrier maintenance: relevance to multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-8016-9

Prophylactic angiotensin type 1 receptor antagonism confers neuroprotection in an aged rat model of postoperative cognitive dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-8016-9

Negative regulation of VEGF-induced vascular leakage by blockade of angiotensin II type 1 receptor.

21 January 2018

1 reference

12 December 2020

MR diffusion imaging of cerebral infarction in humans

1 reference

12 December 2020

Roles for host and tumor angiotensin II type 1 receptor in tumor growth and tumor-associated angiogenesis

1 reference

12 December 2020

In vivo MR determination of water diffusion coefficients and diffusion anisotropy: correlation with structural alteration in gliomas of the cerebral hemispheres

1 reference

12 December 2020

[The renin-angiotensin system in human brain and brain tumors: a function unrelated to blood pressure control?]

1 reference

12 December 2020

10.1007/S00415-015-8016-9

Identifiers

DOI

1 reference

17 February 2018

Dimensions Publication ID

1026759438

0 references

1 reference

17 February 2018